We found that patients with type 1 AIP/IgG4-RD exhibited higher serum concentrations of IgG4, IFN-α, and IL-33, compared with those in patients with CP or HCs. This evidence concerns the gene IFNA1 and immunoglobulin G4-related sclerosing disease.